RT @pnatarajanmd: 1 in 10 heart transplant recipients develop malignancy 1-5y after transplant https://t.co/0DcwWvWbA2 @JACCJournals cc @Ca…
Are we over immunosuppressing ? https://t.co/GJ08zNMEHk
RT @pnatarajanmd: 1 in 10 heart transplant recipients develop malignancy 1-5y after transplant https://t.co/0DcwWvWbA2 @JACCJournals cc @Ca…
واحد من بين كل خمسة مرضى يجرون زراعة قلب يصابون بالسرطان للاسف https://t.co/6Lfwi8NttR
RT @JACCJournals: New #JACC study shows >10% de novo rate of malignancy in heart transplant patients, including skin cancer (7%), non-skin…
RT @JACCJournals: New #JACC study shows >10% de novo rate of malignancy in heart transplant patients, including skin cancer (7%), non-skin…
RT @JACCJournals: New #JACC study shows >10% de novo rate of malignancy in heart transplant patients, including skin cancer (7%), non-skin…
RT @shwinner: This is why we are so concerned and tightly monitor immunosuppression throughout the life of a transplant patient #processimp…
RT @JACCJournals: New #JACC study shows >10% de novo rate of malignancy in heart transplant patients, including skin cancer (7%), non-skin…
RT @shwinner: This is why we are so concerned and tightly monitor immunosuppression throughout the life of a transplant patient #processimp…
This is why we are so concerned and tightly monitor immunosuppression throughout the life of a transplant patient #processimprovement @StVincentIN @MinnowWalsh @SunitChaudhryMD https://t.co/1sVbPq0gTJ
RT @JACCJournals: New #JACC study shows >10% de novo rate of malignancy in heart transplant patients, including skin cancer (7%), non-skin…
RT @JACCJournals: New #JACC study shows >10% de novo rate of malignancy in heart transplant patients, including skin cancer (7%), non-skin…
RT @JACCJournals: New #JACC study shows >10% de novo rate of malignancy in heart transplant patients, including skin cancer (7%), non-skin…
RT @JACCJournals: New #JACC study shows >10% de novo rate of malignancy in heart transplant patients, including skin cancer (7%), non-skin…
RT @JACCJournals: New #JACC study shows >10% de novo rate of malignancy in heart transplant patients, including skin cancer (7%), non-skin…
RT @JACCJournals: New #JACC study shows >10% de novo rate of malignancy in heart transplant patients, including skin cancer (7%), non-skin…
RT @JACCJournals: New #JACC study shows >10% de novo rate of malignancy in heart transplant patients, including skin cancer (7%), non-skin…
RT @JACCJournals: New #JACC study shows >10% de novo rate of malignancy in heart transplant patients, including skin cancer (7%), non-skin…
RT @JACCJournals: New #JACC study shows >10% de novo rate of malignancy in heart transplant patients, including skin cancer (7%), non-skin…
RT @JACCJournals: New #JACC study shows >10% de novo rate of malignancy in heart transplant patients, including skin cancer (7%), non-skin…
RT @JACCJournals: New #JACC study shows >10% de novo rate of malignancy in heart transplant patients, including skin cancer (7%), non-skin…
RT @JACCJournals: New #JACC study shows >10% de novo rate of malignancy in heart transplant patients, including skin cancer (7%), non-skin…
RT @JACCJournals: New #JACC study shows >10% de novo rate of malignancy in heart transplant patients, including skin cancer (7%), non-skin…
New #JACC study shows >10% de novo rate of malignancy in heart transplant patients, including skin cancer (7%), non-skin solid cancer (4%), & lymphoproliferative disorders (0.9%). Can we do better? https://t.co/RrKpJFtvjZ @CedarsSinai https://t.co/b
@pnatarajanmd @JACCJournals A very interesting finding indeed! Wonder if it can all be explained by immunosuppression? #CardioOnc https://t.co/5l0VkYUglH https://t.co/LXGY05mTbH
1 in 10 heart transplant recipients develop malignancy 1-5y after transplant https://t.co/0DcwWvWbA2 @JACCJournals cc @CardioOncology